During the past decade, NZ Respiratory & Sleep Institute conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 1 clinical trials were completed, i.e. on average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 1 clinical trials were completed. i.e. 20% of trials that started reached the finish line.

Out of the total clinical trials conducted in "NZ Respiratory & Sleep Institute" #1 sponsor was "Hoffmann-La Roche" with 4 trials, followed by "Fisher and Paykel Healthcare" with 1 trials sponsored, "Galapagos NV" with 1 trials sponsored, "Genentech, Inc." with 1 trials sponsored and "Grifols Therapeutics LLC" with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

According to Clinical.Site data, the most researched conditions in "NZ Respiratory & Sleep Institute" are "Idiopathic Pulmonary Fibrosis" (4 trials), "Asthma" (2 trials), "Chronic Obstructive Pulmonary Disease" (1 trials), "Hypercapnia" (1 trials) and "Pulmonary Emphysema in Alpha-1 PI Deficiency" (1 trials). Many other conditions were trialed in "NZ Respiratory & Sleep Institute" in a lesser frequency.

Most popular intervention types in "NZ Respiratory & Sleep Institute" are "Drug" (7 trials), "Biological" (1 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (6 trials), "Lebrikizumab" (2 trials), "PRM-151 (Zinpentraxin Alfa)" (2 trials), "0.9% Sodium Chloride for Injection, USP" (1 trials) and "Alpha-1 MP" (1 trials). Other intervention names were less common.

The vast majority of trials in "NZ Respiratory & Sleep Institute" are 9 trials for "All" genders.

Currently, there are NaN active trials in "NZ Respiratory & Sleep Institute". undefined are not yet recruiting, 2 are recruiting, 1 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 3 completed trials in NZ Respiratory & Sleep Institute, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in NZ Respiratory & Sleep Institute, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 5 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".